nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A4—Rivastigmine—Alzheimer's disease	0.115	0.432	CbGbCtD
Fluticasone Propionate—CYP3A4—Donepezil—Alzheimer's disease	0.0917	0.345	CbGbCtD
Fluticasone Propionate—CYP3A4—Galantamine—Alzheimer's disease	0.0591	0.223	CbGbCtD
Fluticasone Propionate—PLA2G4A—Tetrabenazine—Donepezil—Alzheimer's disease	0.0149	1	CbGdCrCtD
Fluticasone Propionate—PGR—blood vessel—Alzheimer's disease	0.00307	0.118	CbGeAlD
Fluticasone Propionate—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.00282	0.00551	CcSEcCtD
Fluticasone Propionate—Ageusia—Rivastigmine—Alzheimer's disease	0.00281	0.00549	CcSEcCtD
Fluticasone Propionate—Stinging—Rivastigmine—Alzheimer's disease	0.00281	0.00549	CcSEcCtD
Fluticasone Propionate—Endocrine disorder—Memantine—Alzheimer's disease	0.00281	0.00548	CcSEcCtD
Fluticasone Propionate—Dysphonia—Rivastigmine—Alzheimer's disease	0.00277	0.00541	CcSEcCtD
Fluticasone Propionate—Extrasystoles—Memantine—Alzheimer's disease	0.00277	0.0054	CcSEcCtD
Fluticasone Propionate—Extrasystoles—Rivastigmine—Alzheimer's disease	0.00271	0.00529	CcSEcCtD
Fluticasone Propionate—Cataract—Donepezil—Alzheimer's disease	0.0027	0.00526	CcSEcCtD
Fluticasone Propionate—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00254	0.00495	CcSEcCtD
Fluticasone Propionate—Viral infection—Rivastigmine—Alzheimer's disease	0.00252	0.00492	CcSEcCtD
Fluticasone Propionate—Wheezing—Donepezil—Alzheimer's disease	0.00249	0.00486	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Rivastigmine—Alzheimer's disease	0.00247	0.00483	CcSEcCtD
Fluticasone Propionate—Cataract—Memantine—Alzheimer's disease	0.00245	0.00478	CcSEcCtD
Fluticasone Propionate—Cataract—Rivastigmine—Alzheimer's disease	0.00239	0.00467	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Memantine—Alzheimer's disease	0.00226	0.00442	CcSEcCtD
Fluticasone Propionate—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.00225	0.0044	CcSEcCtD
Fluticasone Propionate—Candida infection—Memantine—Alzheimer's disease	0.00222	0.00434	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Rivastigmine—Alzheimer's disease	0.00221	0.00432	CcSEcCtD
Fluticasone Propionate—Candida infection—Rivastigmine—Alzheimer's disease	0.00218	0.00425	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Donepezil—Alzheimer's disease	0.00214	0.00418	CcSEcCtD
Fluticasone Propionate—Eczema—Donepezil—Alzheimer's disease	0.00207	0.00404	CcSEcCtD
Fluticasone Propionate—Hyperkinesia—Memantine—Alzheimer's disease	0.00203	0.00397	CcSEcCtD
Fluticasone Propionate—Bronchitis—Galantamine—Alzheimer's disease	0.002	0.0039	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00199	0.00389	CcSEcCtD
Fluticasone Propionate—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.00199	0.00388	CcSEcCtD
Fluticasone Propionate—Atrial fibrillation—Donepezil—Alzheimer's disease	0.00197	0.00384	CcSEcCtD
Fluticasone Propionate—Sleep disorder—Memantine—Alzheimer's disease	0.00195	0.00381	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Donepezil—Alzheimer's disease	0.00195	0.0038	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Memantine—Alzheimer's disease	0.00194	0.00379	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00193	0.00377	CcSEcCtD
Fluticasone Propionate—Sleep disorder—Rivastigmine—Alzheimer's disease	0.00191	0.00373	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.0019	0.00371	CcSEcCtD
Fluticasone Propionate—Eczema—Memantine—Alzheimer's disease	0.00188	0.00367	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00187	0.00366	CcSEcCtD
Fluticasone Propionate—Pneumonia—Galantamine—Alzheimer's disease	0.00186	0.00364	CcSEcCtD
Fluticasone Propionate—Eczema—Rivastigmine—Alzheimer's disease	0.00184	0.00359	CcSEcCtD
Fluticasone Propionate—Face oedema—Donepezil—Alzheimer's disease	0.0018	0.00351	CcSEcCtD
Fluticasone Propionate—Atrial fibrillation—Memantine—Alzheimer's disease	0.00178	0.00348	CcSEcCtD
Fluticasone Propionate—Irritability—Donepezil—Alzheimer's disease	0.00178	0.00347	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Memantine—Alzheimer's disease	0.00177	0.00345	CcSEcCtD
Fluticasone Propionate—Epistaxis—Galantamine—Alzheimer's disease	0.00175	0.00341	CcSEcCtD
Fluticasone Propionate—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.00175	0.00341	CcSEcCtD
Fluticasone Propionate—NR3C2—forebrain—Alzheimer's disease	0.00174	0.067	CbGeAlD
Fluticasone Propionate—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.00173	0.00338	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Donepezil—Alzheimer's disease	0.00168	0.00327	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00167	0.00325	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00163	0.00319	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Donepezil—Alzheimer's disease	0.00162	0.00316	CcSEcCtD
Fluticasone Propionate—Irritability—Memantine—Alzheimer's disease	0.00161	0.00315	CcSEcCtD
Fluticasone Propionate—Asthma—Donepezil—Alzheimer's disease	0.00161	0.00314	CcSEcCtD
Fluticasone Propionate—NR3C2—telencephalon—Alzheimer's disease	0.0016	0.0616	CbGeAlD
Fluticasone Propionate—Face oedema—Rivastigmine—Alzheimer's disease	0.0016	0.00312	CcSEcCtD
Fluticasone Propionate—Eye disorder—Galantamine—Alzheimer's disease	0.00155	0.00303	CcSEcCtD
Fluticasone Propionate—Bronchitis—Donepezil—Alzheimer's disease	0.00155	0.00302	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00154	0.00301	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Galantamine—Alzheimer's disease	0.00154	0.00301	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Memantine—Alzheimer's disease	0.00151	0.00295	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Galantamine—Alzheimer's disease	0.0015	0.00293	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00149	0.00291	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Galantamine—Alzheimer's disease	0.00149	0.0029	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.00148	0.00289	CcSEcCtD
Fluticasone Propionate—Asthma—Memantine—Alzheimer's disease	0.00146	0.00285	CcSEcCtD
Fluticasone Propionate—Mental disorder—Galantamine—Alzheimer's disease	0.00146	0.00284	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00145	0.00283	CcSEcCtD
Fluticasone Propionate—Malnutrition—Galantamine—Alzheimer's disease	0.00145	0.00282	CcSEcCtD
Fluticasone Propionate—Pneumonia—Donepezil—Alzheimer's disease	0.00144	0.00282	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Memantine—Alzheimer's disease	0.00144	0.00281	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Donepezil—Alzheimer's disease	0.00144	0.0028	CcSEcCtD
Fluticasone Propionate—Infestation—Donepezil—Alzheimer's disease	0.00144	0.0028	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00141	0.00274	CcSEcCtD
Fluticasone Propionate—Bronchitis—Memantine—Alzheimer's disease	0.00141	0.00274	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Donepezil—Alzheimer's disease	0.0014	0.00272	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Galantamine—Alzheimer's disease	0.00139	0.00272	CcSEcCtD
Fluticasone Propionate—Bronchitis—Rivastigmine—Alzheimer's disease	0.00138	0.00268	CcSEcCtD
Fluticasone Propionate—Vision blurred—Galantamine—Alzheimer's disease	0.00136	0.00266	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00136	0.00265	CcSEcCtD
Fluticasone Propionate—Tremor—Galantamine—Alzheimer's disease	0.00136	0.00265	CcSEcCtD
Fluticasone Propionate—Epistaxis—Donepezil—Alzheimer's disease	0.00135	0.00264	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00134	0.00262	CcSEcCtD
Fluticasone Propionate—Agitation—Galantamine—Alzheimer's disease	0.00133	0.0026	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00133	0.00259	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Memantine—Alzheimer's disease	0.00132	0.00257	CcSEcCtD
Fluticasone Propionate—Pneumonia—Memantine—Alzheimer's disease	0.00131	0.00256	CcSEcCtD
Fluticasone Propionate—Malaise—Galantamine—Alzheimer's disease	0.00131	0.00255	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Memantine—Alzheimer's disease	0.0013	0.00254	CcSEcCtD
Fluticasone Propionate—Infestation—Memantine—Alzheimer's disease	0.0013	0.00254	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00129	0.00252	CcSEcCtD
Fluticasone Propionate—Pneumonia—Rivastigmine—Alzheimer's disease	0.00128	0.0025	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00128	0.0025	CcSEcCtD
Fluticasone Propionate—Palpitations—Galantamine—Alzheimer's disease	0.00128	0.0025	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Donepezil—Alzheimer's disease	0.00128	0.0025	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00127	0.00249	CcSEcCtD
Fluticasone Propionate—Infestation—Rivastigmine—Alzheimer's disease	0.00127	0.00249	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Memantine—Alzheimer's disease	0.00127	0.00247	CcSEcCtD
Fluticasone Propionate—Cough—Galantamine—Alzheimer's disease	0.00126	0.00246	CcSEcCtD
Fluticasone Propionate—Hypertension—Galantamine—Alzheimer's disease	0.00125	0.00244	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00124	0.00242	CcSEcCtD
Fluticasone Propionate—Chest pain—Galantamine—Alzheimer's disease	0.00123	0.0024	CcSEcCtD
Fluticasone Propionate—Arthralgia—Galantamine—Alzheimer's disease	0.00123	0.0024	CcSEcCtD
Fluticasone Propionate—Epistaxis—Memantine—Alzheimer's disease	0.00123	0.0024	CcSEcCtD
Fluticasone Propionate—Anxiety—Galantamine—Alzheimer's disease	0.00123	0.0024	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00122	0.00239	CcSEcCtD
Fluticasone Propionate—Sinusitis—Memantine—Alzheimer's disease	0.00122	0.00239	CcSEcCtD
Fluticasone Propionate—Discomfort—Galantamine—Alzheimer's disease	0.00122	0.00238	CcSEcCtD
Fluticasone Propionate—Dry mouth—Galantamine—Alzheimer's disease	0.00121	0.00235	CcSEcCtD
Fluticasone Propionate—Epistaxis—Rivastigmine—Alzheimer's disease	0.0012	0.00235	CcSEcCtD
Fluticasone Propionate—Sinusitis—Rivastigmine—Alzheimer's disease	0.0012	0.00233	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Memantine—Alzheimer's disease	0.00116	0.00227	CcSEcCtD
Fluticasone Propionate—PLA2G4A—nervous system—Alzheimer's disease	0.00116	0.0447	CbGeAlD
Fluticasone Propionate—Pharyngitis—Memantine—Alzheimer's disease	0.00116	0.00227	CcSEcCtD
Fluticasone Propionate—SERPINA6—nervous system—Alzheimer's disease	0.00116	0.0446	CbGeAlD
Fluticasone Propionate—Nervous system disorder—Galantamine—Alzheimer's disease	0.00116	0.00226	CcSEcCtD
Fluticasone Propionate—Tachycardia—Galantamine—Alzheimer's disease	0.00115	0.00225	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Donepezil—Alzheimer's disease	0.00115	0.00225	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Memantine—Alzheimer's disease	0.00115	0.00224	CcSEcCtD
Fluticasone Propionate—Skin disorder—Galantamine—Alzheimer's disease	0.00115	0.00224	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00114	0.00222	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00114	0.00222	CcSEcCtD
Fluticasone Propionate—Mental disorder—Donepezil—Alzheimer's disease	0.00113	0.0022	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00112	0.00219	CcSEcCtD
Fluticasone Propionate—Erythema—Donepezil—Alzheimer's disease	0.00112	0.00219	CcSEcCtD
Fluticasone Propionate—Malnutrition—Donepezil—Alzheimer's disease	0.00112	0.00219	CcSEcCtD
Fluticasone Propionate—PLA2G4A—central nervous system—Alzheimer's disease	0.00112	0.0431	CbGeAlD
Fluticasone Propionate—SERPINA6—central nervous system—Alzheimer's disease	0.00112	0.0429	CbGeAlD
Fluticasone Propionate—Eye disorder—Memantine—Alzheimer's disease	0.00109	0.00213	CcSEcCtD
Fluticasone Propionate—SERPINA6—cerebellum—Alzheimer's disease	0.00109	0.0419	CbGeAlD
Fluticasone Propionate—Cardiac disorder—Memantine—Alzheimer's disease	0.00109	0.00212	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Donepezil—Alzheimer's disease	0.00108	0.0021	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00108	0.0021	CcSEcCtD
Fluticasone Propionate—Eye disorder—Rivastigmine—Alzheimer's disease	0.00107	0.00209	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00106	0.00207	CcSEcCtD
Fluticasone Propionate—Vision blurred—Donepezil—Alzheimer's disease	0.00106	0.00206	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Memantine—Alzheimer's disease	0.00106	0.00206	CcSEcCtD
Fluticasone Propionate—NR3C1—embryo—Alzheimer's disease	0.00106	0.0406	CbGeAlD
Fluticasone Propionate—Mediastinal disorder—Memantine—Alzheimer's disease	0.00105	0.00206	CcSEcCtD
Fluticasone Propionate—Tremor—Donepezil—Alzheimer's disease	0.00105	0.00205	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Memantine—Alzheimer's disease	0.00105	0.00204	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00104	0.00203	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00103	0.00201	CcSEcCtD
Fluticasone Propionate—Agitation—Donepezil—Alzheimer's disease	0.00103	0.00201	CcSEcCtD
Fluticasone Propionate—Mental disorder—Memantine—Alzheimer's disease	0.00102	0.002	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00102	0.002	CcSEcCtD
Fluticasone Propionate—Malnutrition—Memantine—Alzheimer's disease	0.00102	0.00199	CcSEcCtD
Fluticasone Propionate—Malaise—Donepezil—Alzheimer's disease	0.00101	0.00197	CcSEcCtD
Fluticasone Propionate—Mental disorder—Rivastigmine—Alzheimer's disease	0.001	0.00196	CcSEcCtD
Fluticasone Propionate—Malnutrition—Rivastigmine—Alzheimer's disease	0.000996	0.00194	CcSEcCtD
Fluticasone Propionate—Erythema—Rivastigmine—Alzheimer's disease	0.000996	0.00194	CcSEcCtD
Fluticasone Propionate—Cough—Donepezil—Alzheimer's disease	0.000979	0.00191	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Galantamine—Alzheimer's disease	0.000973	0.0019	CcSEcCtD
Fluticasone Propionate—Hypertension—Donepezil—Alzheimer's disease	0.000968	0.00189	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000966	0.00189	CcSEcCtD
Fluticasone Propionate—Vision blurred—Memantine—Alzheimer's disease	0.00096	0.00187	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000958	0.00187	CcSEcCtD
Fluticasone Propionate—Arthralgia—Donepezil—Alzheimer's disease	0.000955	0.00186	CcSEcCtD
Fluticasone Propionate—Chest pain—Donepezil—Alzheimer's disease	0.000955	0.00186	CcSEcCtD
Fluticasone Propionate—Tremor—Memantine—Alzheimer's disease	0.000954	0.00186	CcSEcCtD
Fluticasone Propionate—Anxiety—Donepezil—Alzheimer's disease	0.000952	0.00186	CcSEcCtD
Fluticasone Propionate—NR3C2—nervous system—Alzheimer's disease	0.000946	0.0364	CbGeAlD
Fluticasone Propionate—Ill-defined disorder—Memantine—Alzheimer's disease	0.000945	0.00184	CcSEcCtD
Fluticasone Propionate—Discomfort—Donepezil—Alzheimer's disease	0.000943	0.00184	CcSEcCtD
Fluticasone Propionate—Vision blurred—Rivastigmine—Alzheimer's disease	0.000939	0.00183	CcSEcCtD
Fluticasone Propionate—Agitation—Memantine—Alzheimer's disease	0.000936	0.00183	CcSEcCtD
Fluticasone Propionate—NR3C1—forebrain—Alzheimer's disease	0.000935	0.0359	CbGeAlD
Fluticasone Propionate—Dry mouth—Donepezil—Alzheimer's disease	0.000934	0.00182	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Galantamine—Alzheimer's disease	0.000934	0.00182	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Galantamine—Alzheimer's disease	0.000934	0.00182	CcSEcCtD
Fluticasone Propionate—Tremor—Rivastigmine—Alzheimer's disease	0.000933	0.00182	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000924	0.0018	CcSEcCtD
Fluticasone Propionate—Malaise—Memantine—Alzheimer's disease	0.000918	0.00179	CcSEcCtD
Fluticasone Propionate—Agitation—Rivastigmine—Alzheimer's disease	0.000916	0.00179	CcSEcCtD
Fluticasone Propionate—Oedema—Donepezil—Alzheimer's disease	0.000915	0.00179	CcSEcCtD
Fluticasone Propionate—NR3C2—central nervous system—Alzheimer's disease	0.000911	0.035	CbGeAlD
Fluticasone Propionate—Infection—Donepezil—Alzheimer's disease	0.000909	0.00177	CcSEcCtD
Fluticasone Propionate—Palpitations—Memantine—Alzheimer's disease	0.0009	0.00176	CcSEcCtD
Fluticasone Propionate—Malaise—Rivastigmine—Alzheimer's disease	0.000898	0.00175	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Donepezil—Alzheimer's disease	0.000898	0.00175	CcSEcCtD
Fluticasone Propionate—NR3C2—cerebellum—Alzheimer's disease	0.00089	0.0342	CbGeAlD
Fluticasone Propionate—PLA2G4A—brain—Alzheimer's disease	0.000889	0.0342	CbGeAlD
Fluticasone Propionate—Cough—Memantine—Alzheimer's disease	0.000889	0.00173	CcSEcCtD
Fluticasone Propionate—SERPINA6—brain—Alzheimer's disease	0.000885	0.0341	CbGeAlD
Fluticasone Propionate—Palpitations—Rivastigmine—Alzheimer's disease	0.00088	0.00172	CcSEcCtD
Fluticasone Propionate—Hypertension—Memantine—Alzheimer's disease	0.000879	0.00172	CcSEcCtD
Fluticasone Propionate—PGR—nervous system—Alzheimer's disease	0.000879	0.0338	CbGeAlD
Fluticasone Propionate—Hypersensitivity—Galantamine—Alzheimer's disease	0.00087	0.0017	CcSEcCtD
Fluticasone Propionate—Cough—Rivastigmine—Alzheimer's disease	0.000869	0.0017	CcSEcCtD
Fluticasone Propionate—Arthralgia—Memantine—Alzheimer's disease	0.000867	0.00169	CcSEcCtD
Fluticasone Propionate—Chest pain—Memantine—Alzheimer's disease	0.000867	0.00169	CcSEcCtD
Fluticasone Propionate—Anxiety—Memantine—Alzheimer's disease	0.000864	0.00169	CcSEcCtD
Fluticasone Propionate—Hypertension—Rivastigmine—Alzheimer's disease	0.00086	0.00168	CcSEcCtD
Fluticasone Propionate—NR3C1—telencephalon—Alzheimer's disease	0.000859	0.0331	CbGeAlD
Fluticasone Propionate—Discomfort—Memantine—Alzheimer's disease	0.000857	0.00167	CcSEcCtD
Fluticasone Propionate—Arthralgia—Rivastigmine—Alzheimer's disease	0.000848	0.00166	CcSEcCtD
Fluticasone Propionate—Chest pain—Rivastigmine—Alzheimer's disease	0.000848	0.00166	CcSEcCtD
Fluticasone Propionate—Dry mouth—Memantine—Alzheimer's disease	0.000848	0.00165	CcSEcCtD
Fluticasone Propionate—PGR—central nervous system—Alzheimer's disease	0.000846	0.0326	CbGeAlD
Fluticasone Propionate—Anxiety—Rivastigmine—Alzheimer's disease	0.000845	0.00165	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000842	0.00164	CcSEcCtD
Fluticasone Propionate—Discomfort—Rivastigmine—Alzheimer's disease	0.000838	0.00164	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000834	0.00163	CcSEcCtD
Fluticasone Propionate—Oedema—Memantine—Alzheimer's disease	0.000831	0.00162	CcSEcCtD
Fluticasone Propionate—Dry mouth—Rivastigmine—Alzheimer's disease	0.00083	0.00162	CcSEcCtD
Fluticasone Propionate—PGR—cerebellum—Alzheimer's disease	0.000827	0.0318	CbGeAlD
Fluticasone Propionate—Infection—Memantine—Alzheimer's disease	0.000826	0.00161	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Donepezil—Alzheimer's disease	0.000816	0.00159	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Memantine—Alzheimer's disease	0.000815	0.00159	CcSEcCtD
Fluticasone Propionate—Oedema—Rivastigmine—Alzheimer's disease	0.000813	0.00159	CcSEcCtD
Fluticasone Propionate—Tachycardia—Memantine—Alzheimer's disease	0.000811	0.00158	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Galantamine—Alzheimer's disease	0.000808	0.00158	CcSEcCtD
Fluticasone Propionate—Infection—Rivastigmine—Alzheimer's disease	0.000808	0.00158	CcSEcCtD
Fluticasone Propionate—Skin disorder—Memantine—Alzheimer's disease	0.000807	0.00158	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000797	0.00156	CcSEcCtD
Fluticasone Propionate—Tachycardia—Rivastigmine—Alzheimer's disease	0.000794	0.00155	CcSEcCtD
Fluticasone Propionate—Skin disorder—Rivastigmine—Alzheimer's disease	0.00079	0.00154	CcSEcCtD
Fluticasone Propionate—Pain—Donepezil—Alzheimer's disease	0.000783	0.00153	CcSEcCtD
Fluticasone Propionate—Dizziness—Galantamine—Alzheimer's disease	0.000781	0.00152	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000757	0.00148	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Donepezil—Alzheimer's disease	0.000754	0.00147	CcSEcCtD
Fluticasone Propionate—Vomiting—Galantamine—Alzheimer's disease	0.000751	0.00147	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000749	0.00146	CcSEcCtD
Fluticasone Propionate—Rash—Galantamine—Alzheimer's disease	0.000745	0.00145	CcSEcCtD
Fluticasone Propionate—Dermatitis—Galantamine—Alzheimer's disease	0.000744	0.00145	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Memantine—Alzheimer's disease	0.000741	0.00145	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000741	0.00145	CcSEcCtD
Fluticasone Propionate—Headache—Galantamine—Alzheimer's disease	0.00074	0.00144	CcSEcCtD
Fluticasone Propionate—Urticaria—Donepezil—Alzheimer's disease	0.000727	0.00142	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000725	0.00141	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Donepezil—Alzheimer's disease	0.000724	0.00141	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Donepezil—Alzheimer's disease	0.000724	0.00141	CcSEcCtD
Fluticasone Propionate—NR3C2—brain—Alzheimer's disease	0.000723	0.0278	CbGeAlD
Fluticasone Propionate—Pain—Memantine—Alzheimer's disease	0.000711	0.00139	CcSEcCtD
Fluticasone Propionate—Nausea—Galantamine—Alzheimer's disease	0.000702	0.00137	CcSEcCtD
Fluticasone Propionate—Pain—Rivastigmine—Alzheimer's disease	0.000695	0.00136	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Memantine—Alzheimer's disease	0.000685	0.00134	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00068	0.00133	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Donepezil—Alzheimer's disease	0.000674	0.00132	CcSEcCtD
Fluticasone Propionate—PGR—brain—Alzheimer's disease	0.000672	0.0258	CbGeAlD
Fluticasone Propionate—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00067	0.00131	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000665	0.0013	CcSEcCtD
Fluticasone Propionate—Urticaria—Memantine—Alzheimer's disease	0.00066	0.00129	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Memantine—Alzheimer's disease	0.000657	0.00128	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Memantine—Alzheimer's disease	0.000657	0.00128	CcSEcCtD
Fluticasone Propionate—Pruritus—Donepezil—Alzheimer's disease	0.000648	0.00126	CcSEcCtD
Fluticasone Propionate—Urticaria—Rivastigmine—Alzheimer's disease	0.000646	0.00126	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000643	0.00125	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000643	0.00125	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Donepezil—Alzheimer's disease	0.000626	0.00122	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Memantine—Alzheimer's disease	0.000612	0.0012	CcSEcCtD
Fluticasone Propionate—Dizziness—Donepezil—Alzheimer's disease	0.000605	0.00118	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000599	0.00117	CcSEcCtD
Fluticasone Propionate—Pruritus—Memantine—Alzheimer's disease	0.000588	0.00115	CcSEcCtD
Fluticasone Propionate—Vomiting—Donepezil—Alzheimer's disease	0.000582	0.00114	CcSEcCtD
Fluticasone Propionate—Rash—Donepezil—Alzheimer's disease	0.000577	0.00113	CcSEcCtD
Fluticasone Propionate—Dermatitis—Donepezil—Alzheimer's disease	0.000577	0.00113	CcSEcCtD
Fluticasone Propionate—Pruritus—Rivastigmine—Alzheimer's disease	0.000575	0.00112	CcSEcCtD
Fluticasone Propionate—Headache—Donepezil—Alzheimer's disease	0.000573	0.00112	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Memantine—Alzheimer's disease	0.000569	0.00111	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000556	0.00109	CcSEcCtD
Fluticasone Propionate—Dizziness—Memantine—Alzheimer's disease	0.00055	0.00107	CcSEcCtD
Fluticasone Propionate—Nausea—Donepezil—Alzheimer's disease	0.000544	0.00106	CcSEcCtD
Fluticasone Propionate—Dizziness—Rivastigmine—Alzheimer's disease	0.000538	0.00105	CcSEcCtD
Fluticasone Propionate—Vomiting—Memantine—Alzheimer's disease	0.000528	0.00103	CcSEcCtD
Fluticasone Propionate—Rash—Memantine—Alzheimer's disease	0.000524	0.00102	CcSEcCtD
Fluticasone Propionate—Dermatitis—Memantine—Alzheimer's disease	0.000524	0.00102	CcSEcCtD
Fluticasone Propionate—Headache—Memantine—Alzheimer's disease	0.000521	0.00102	CcSEcCtD
Fluticasone Propionate—Vomiting—Rivastigmine—Alzheimer's disease	0.000517	0.00101	CcSEcCtD
Fluticasone Propionate—Rash—Rivastigmine—Alzheimer's disease	0.000513	0.001	CcSEcCtD
Fluticasone Propionate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000512	0.001	CcSEcCtD
Fluticasone Propionate—Headache—Rivastigmine—Alzheimer's disease	0.000509	0.000994	CcSEcCtD
Fluticasone Propionate—Triamcinolone—BCHE—Alzheimer's disease	0.000509	0.324	CrCbGaD
Fluticasone Propionate—NR3C1—nervous system—Alzheimer's disease	0.000507	0.0195	CbGeAlD
Fluticasone Propionate—Nausea—Memantine—Alzheimer's disease	0.000494	0.000964	CcSEcCtD
Fluticasone Propionate—NR3C1—central nervous system—Alzheimer's disease	0.000488	0.0188	CbGeAlD
Fluticasone Propionate—Nausea—Rivastigmine—Alzheimer's disease	0.000483	0.000943	CcSEcCtD
Fluticasone Propionate—NR3C1—cerebellum—Alzheimer's disease	0.000477	0.0184	CbGeAlD
Fluticasone Propionate—Dexamethasone—NOS2—Alzheimer's disease	0.000389	0.248	CrCbGaD
Fluticasone Propionate—NR3C1—brain—Alzheimer's disease	0.000388	0.0149	CbGeAlD
Fluticasone Propionate—CYP3A4—nervous system—Alzheimer's disease	0.000384	0.0148	CbGeAlD
Fluticasone Propionate—CYP3A4—central nervous system—Alzheimer's disease	0.000369	0.0142	CbGeAlD
Fluticasone Propionate—Triamcinolone—PTGS2—Alzheimer's disease	0.000234	0.149	CrCbGaD
Fluticasone Propionate—Betamethasone—PTGS2—Alzheimer's disease	0.000192	0.122	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP2D6—Alzheimer's disease	0.000133	0.0848	CrCbGaD
Fluticasone Propionate—Dexamethasone—PTGS2—Alzheimer's disease	0.000112	0.0712	CrCbGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MAOB—Alzheimer's disease	8.75e-05	0.000487	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—APP—Alzheimer's disease	8.72e-05	0.000486	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—F2—Alzheimer's disease	8.62e-05	0.00048	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NOS2—Alzheimer's disease	8.52e-05	0.000474	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PSENEN—Alzheimer's disease	8.44e-05	0.000469	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GAPDH—Alzheimer's disease	8.42e-05	0.000469	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	8.39e-05	0.000467	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—PPARG—Alzheimer's disease	8.35e-05	0.000465	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.32e-05	0.000463	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—A2M—Alzheimer's disease	8.32e-05	0.000463	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APH1A—Alzheimer's disease	8.32e-05	0.000463	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.25e-05	0.000459	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PLCB1—Alzheimer's disease	8.23e-05	0.000458	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—A2M—Alzheimer's disease	8.13e-05	0.000453	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	8.13e-05	0.000452	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NCSTN—Alzheimer's disease	8.1e-05	0.000451	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PSEN2—Alzheimer's disease	8.06e-05	0.000449	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PLD3—Alzheimer's disease	8e-05	0.000445	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LRP1—Alzheimer's disease	7.9e-05	0.00044	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GFAP—Alzheimer's disease	7.71e-05	0.000429	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GAL—Alzheimer's disease	7.71e-05	0.000429	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	7.67e-05	0.000427	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	7.67e-05	0.000427	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IGF1—Alzheimer's disease	7.56e-05	0.000421	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NPY—Alzheimer's disease	7.42e-05	0.000413	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	7.38e-05	0.000411	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IAPP—Alzheimer's disease	7.37e-05	0.00041	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.25e-05	0.000404	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—IL6—Alzheimer's disease	7.16e-05	0.000399	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CRH—Alzheimer's disease	7.16e-05	0.000398	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ND1—Alzheimer's disease	7.13e-05	0.000397	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ACHE—Alzheimer's disease	7.07e-05	0.000394	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—INPP5D—Alzheimer's disease	6.99e-05	0.000389	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	6.87e-05	0.000382	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NOS3—Alzheimer's disease	6.85e-05	0.000381	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—A2M—Alzheimer's disease	6.8e-05	0.000378	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NPS—Alzheimer's disease	6.78e-05	0.000378	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PPP3CA—Alzheimer's disease	6.75e-05	0.000376	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	6.69e-05	0.000372	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTK2B—Alzheimer's disease	6.65e-05	0.00037	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ENO1—Alzheimer's disease	6.63e-05	0.000369	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS1—Alzheimer's disease	6.63e-05	0.000369	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	6.59e-05	0.000367	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PSEN2—Alzheimer's disease	6.58e-05	0.000367	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP2D6—Alzheimer's disease	6.5e-05	0.000362	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GAB2—Alzheimer's disease	6.47e-05	0.00036	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NTRK2—Alzheimer's disease	6.47e-05	0.00036	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SST—Alzheimer's disease	6.47e-05	0.00036	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	6.47e-05	0.00036	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GSK3A—Alzheimer's disease	6.42e-05	0.000357	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CHAT—Alzheimer's disease	6.36e-05	0.000354	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TPI1—Alzheimer's disease	6.36e-05	0.000354	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APP—Alzheimer's disease	6.31e-05	0.000351	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	6.19e-05	0.000345	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—BCHE—Alzheimer's disease	6.16e-05	0.000343	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	6.11e-05	0.00034	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	6.1e-05	0.00034	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MAOB—Alzheimer's disease	6.1e-05	0.000339	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PRKCG—Alzheimer's disease	6.09e-05	0.000339	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NPY—Alzheimer's disease	6.06e-05	0.000337	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IAPP—Alzheimer's disease	6.02e-05	0.000335	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PLCB1—Alzheimer's disease	5.95e-05	0.000331	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GAPDH—Alzheimer's disease	5.87e-05	0.000327	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CRH—Alzheimer's disease	5.85e-05	0.000325	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PLCB1—Alzheimer's disease	5.81e-05	0.000324	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCR5—Alzheimer's disease	5.77e-05	0.000321	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.7e-05	0.000317	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—A2M—Alzheimer's disease	5.67e-05	0.000315	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HTR2A—Alzheimer's disease	5.64e-05	0.000314	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ABCA1—Alzheimer's disease	5.64e-05	0.000314	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—ESR1—Alzheimer's disease	5.57e-05	0.00031	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NGFR—Alzheimer's disease	5.55e-05	0.000309	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NPS—Alzheimer's disease	5.54e-05	0.000309	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PPP3CA—Alzheimer's disease	5.52e-05	0.000307	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTK2B—Alzheimer's disease	5.44e-05	0.000303	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ADAM10—Alzheimer's disease	5.42e-05	0.000302	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NOTCH1—Alzheimer's disease	5.39e-05	0.0003	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NTRK2—Alzheimer's disease	5.29e-05	0.000294	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GAB2—Alzheimer's disease	5.29e-05	0.000294	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SST—Alzheimer's disease	5.29e-05	0.000294	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CALM1—Alzheimer's disease	5.27e-05	0.000293	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GSK3A—Alzheimer's disease	5.24e-05	0.000292	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APP—Alzheimer's disease	5.15e-05	0.000287	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.15e-05	0.000286	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—S100B—Alzheimer's disease	5.13e-05	0.000285	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PPARG—Alzheimer's disease	5.08e-05	0.000283	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—F2—Alzheimer's disease	4.95e-05	0.000275	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—Alzheimer's disease	4.94e-05	0.000275	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ACHE—Alzheimer's disease	4.93e-05	0.000274	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF2—Alzheimer's disease	4.88e-05	0.000272	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	4.87e-05	0.000271	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PLCB1—Alzheimer's disease	4.86e-05	0.000271	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARGC1A—Alzheimer's disease	4.86e-05	0.00027	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—HMOX1—Alzheimer's disease	4.84e-05	0.000269	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1R—Alzheimer's disease	4.72e-05	0.000263	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	4.62e-05	0.000257	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ENO1—Alzheimer's disease	4.62e-05	0.000257	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CHAT—Alzheimer's disease	4.6e-05	0.000256	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TPI1—Alzheimer's disease	4.6e-05	0.000256	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NGFR—Alzheimer's disease	4.54e-05	0.000253	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	4.53e-05	0.000252	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB1—Alzheimer's disease	4.53e-05	0.000252	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LPL—Alzheimer's disease	4.53e-05	0.000252	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CREB1—Alzheimer's disease	4.51e-05	0.000251	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MEF2C—Alzheimer's disease	4.49e-05	0.00025	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ADAM10—Alzheimer's disease	4.43e-05	0.000247	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—LPL—Alzheimer's disease	4.42e-05	0.000246	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCL2—Alzheimer's disease	4.41e-05	0.000245	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MAOB—Alzheimer's disease	4.41e-05	0.000245	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PRKCG—Alzheimer's disease	4.4e-05	0.000245	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.37e-05	0.000244	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—BCHE—Alzheimer's disease	4.29e-05	0.000239	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NGF—Alzheimer's disease	4.29e-05	0.000239	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	4.24e-05	0.000236	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—S100B—Alzheimer's disease	4.19e-05	0.000233	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCR5—Alzheimer's disease	4.17e-05	0.000232	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.11e-05	0.000229	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—A2M—Alzheimer's disease	4.1e-05	0.000228	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HTR2A—Alzheimer's disease	4.08e-05	0.000227	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	4.05e-05	0.000226	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF2—Alzheimer's disease	3.99e-05	0.000222	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MTHFR—Alzheimer's disease	3.98e-05	0.000222	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	3.93e-05	0.000219	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.9e-05	0.000217	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1R—Alzheimer's disease	3.86e-05	0.000215	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CALM1—Alzheimer's disease	3.81e-05	0.000212	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APOE—Alzheimer's disease	3.79e-05	0.000211	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LEP—Alzheimer's disease	3.79e-05	0.000211	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CAV1—Alzheimer's disease	3.76e-05	0.000209	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—Alzheimer's disease	3.73e-05	0.000208	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CALM1—Alzheimer's disease	3.72e-05	0.000207	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.72e-05	0.000207	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APOE—Alzheimer's disease	3.71e-05	0.000206	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LPL—Alzheimer's disease	3.7e-05	0.000206	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CAV1—Alzheimer's disease	3.67e-05	0.000204	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MEF2C—Alzheimer's disease	3.67e-05	0.000204	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ESR1—Alzheimer's disease	3.62e-05	0.000202	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PRKCG—Alzheimer's disease	3.6e-05	0.0002	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—F2—Alzheimer's disease	3.58e-05	0.000199	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.57e-05	0.000199	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ACHE—Alzheimer's disease	3.56e-05	0.000198	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	3.52e-05	0.000196	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NGF—Alzheimer's disease	3.5e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH1—Alzheimer's disease	3.5e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.43e-05	0.000191	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCR5—Alzheimer's disease	3.41e-05	0.00019	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	3.39e-05	0.000188	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	3.37e-05	0.000188	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ENO1—Alzheimer's disease	3.34e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	3.34e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HTR2A—Alzheimer's disease	3.33e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.32e-05	0.000185	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—Alzheimer's disease	3.3e-05	0.000184	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GSK3B—Alzheimer's disease	3.29e-05	0.000183	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	3.27e-05	0.000182	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CREB1—Alzheimer's disease	3.26e-05	0.000181	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—INS—Alzheimer's disease	3.24e-05	0.00018	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARG—Alzheimer's disease	3.23e-05	0.00018	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR1—Alzheimer's disease	3.22e-05	0.000179	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCL2—Alzheimer's disease	3.19e-05	0.000178	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—INS—Alzheimer's disease	3.17e-05	0.000176	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—Alzheimer's disease	3.15e-05	0.000175	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1—Alzheimer's disease	3.14e-05	0.000175	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	3.11e-05	0.000173	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CALM1—Alzheimer's disease	3.11e-05	0.000173	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—BCHE—Alzheimer's disease	3.1e-05	0.000173	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOE—Alzheimer's disease	3.1e-05	0.000173	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LEP—Alzheimer's disease	3.1e-05	0.000173	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—LPL—Alzheimer's disease	3.08e-05	0.000172	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CAV1—Alzheimer's disease	3.07e-05	0.000171	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ESR1—Alzheimer's disease	2.96e-05	0.000165	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARG—Alzheimer's disease	2.94e-05	0.000164	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	2.93e-05	0.000163	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—F2—Alzheimer's disease	2.92e-05	0.000163	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.86e-05	0.000159	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOS3—Alzheimer's disease	2.84e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	2.84e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NOS3—Alzheimer's disease	2.78e-05	0.000155	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	2.78e-05	0.000154	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GSK3B—Alzheimer's disease	2.68e-05	0.000149	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CREB1—Alzheimer's disease	2.66e-05	0.000148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—INS—Alzheimer's disease	2.65e-05	0.000147	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCL2—Alzheimer's disease	2.61e-05	0.000145	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CALM1—Alzheimer's disease	2.59e-05	0.000144	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOE—Alzheimer's disease	2.58e-05	0.000144	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1—Alzheimer's disease	2.56e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CAV1—Alzheimer's disease	2.56e-05	0.000142	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—Alzheimer's disease	2.54e-05	0.000141	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	2.45e-05	0.000136	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	2.44e-05	0.000136	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP3—Alzheimer's disease	2.41e-05	0.000134	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOS3—Alzheimer's disease	2.32e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARG—Alzheimer's disease	2.25e-05	0.000125	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LPL—Alzheimer's disease	2.23e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK8—Alzheimer's disease	2.22e-05	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—INS—Alzheimer's disease	2.21e-05	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.14e-05	0.000119	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.14e-05	0.000119	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.05e-05	0.000114	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—Alzheimer's disease	2.05e-05	0.000114	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—Alzheimer's disease	2.01e-05	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	2.01e-05	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.97e-05	0.00011	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP3—Alzheimer's disease	1.97e-05	0.00011	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—Alzheimer's disease	1.96e-05	0.000109	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NOS3—Alzheimer's disease	1.94e-05	0.000108	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.9e-05	0.000106	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—Alzheimer's disease	1.88e-05	0.000105	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CALM1—Alzheimer's disease	1.87e-05	0.000104	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOE—Alzheimer's disease	1.87e-05	0.000104	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CAV1—Alzheimer's disease	1.85e-05	0.000103	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK8—Alzheimer's disease	1.81e-05	0.000101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—Alzheimer's disease	1.81e-05	0.000101	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	1.77e-05	9.85e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—Alzheimer's disease	1.67e-05	9.31e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.66e-05	9.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.64e-05	9.11e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.63e-05	9.05e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—INS—Alzheimer's disease	1.6e-05	8.88e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.55e-05	8.64e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.55e-05	8.64e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—Alzheimer's disease	1.55e-05	8.61e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—Alzheimer's disease	1.54e-05	8.55e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.52e-05	8.47e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.44e-05	8.03e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—Alzheimer's disease	1.42e-05	7.88e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.4e-05	7.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.36e-05	7.58e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.32e-05	7.35e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—Alzheimer's disease	1.31e-05	7.27e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.28e-05	7.12e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—Alzheimer's disease	1.28e-05	7.11e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—Alzheimer's disease	1.26e-05	7.04e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—Alzheimer's disease	1.16e-05	6.47e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—Alzheimer's disease	1.16e-05	6.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.14e-05	6.33e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.13e-05	6.3e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—Alzheimer's disease	1.07e-05	5.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.04e-05	5.77e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	9.33e-06	5.19e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—Alzheimer's disease	8.9e-06	4.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CALM1—Alzheimer's disease	8.71e-06	4.85e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOE—Alzheimer's disease	8.68e-06	4.83e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CAV1—Alzheimer's disease	8.6e-06	4.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARG—Alzheimer's disease	7.56e-06	4.21e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—INS—Alzheimer's disease	7.42e-06	4.13e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NOS3—Alzheimer's disease	6.5e-06	3.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—Alzheimer's disease	6.43e-06	3.58e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.95e-06	3.31e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.99e-06	1.66e-05	CbGpPWpGaD
